Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Galapagos N.V.
DescriptionDNA polymerase III alpha inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat bacterial infection, including all drug-resistant forms of Staphylococcus aureus
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today